Cancer patients and oncologists are dealing with an alarming shortage of critical chemotherapy drugs. Specifically, oncologists have short supplies of platinum-based generic drugs called cisplatin and carboplatin used to treat lung, breast, bladder, ovarian, endometrial and head and neck cancers.